BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.95%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$9.45B
(+8.2%)
Cap. Flow
+$607M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$53.3M |
| 2 |
ESSA Pharma
EPIX
|
$53M |
| 3 |
Revolution Medicines
RVMD
|
$47.1M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$39.8M |
| 5 |
Becton Dickinson
BDX
|
$32.4M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$100M |
| 2 |
Halozyme
HALO
|
$43.1M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$38.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$33.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$32.2M |
Sector Composition
| 1 | Healthcare | 95.93% |
| 2 | Industrials | 0.88% |
| 3 | Technology | 0.47% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Inspire Medical Systems
INSP
$2.53B
| $66.3M | 0.7% |
320,188
+20,971
| +7% | +$4.34M |
|
|
SWAV
52
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $63.1M | 0.67% |
484,564
+59,229
| +14% | +$7.72M |
|
|
SILK
53
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $58.7M | 0.62% |
1,158,924
+786,034
| +211% | +$39.8M |
|
54
Bio-Rad Laboratories Class A
BIO
$7.8B
| $57.2M | 0.61% |
100,202
+35,797
| +56% | +$20.4M |
|
55
Charles River Laboratories
CRL
$7.99B
| $54.6M | 0.58% |
188,385
+45,367
| +32% | +$13.1M |
|
56
Black Diamond Therapeutics
BDTX
$164M
| $54.4M | 0.58% |
2,243,000
+840,000
| +60% | +$20.4M |
|
57
Pacific Biosciences
PACB
$378M
| $53.9M | 0.57% |
1,617,505
-80,674
| -5% | -$2.69M |
|
|
58
ESSA Pharma
EPIX
$11.2M
| $53M | 0.56% |
+1,825,814
| New | +$53M |
|
59
Teleflex
TFX
$5.57B
| $50.4M | 0.53% |
121,361
+3,583
| +3% | +$1.49M |
|
|
60
Revolution Medicines
RVMD
$7.43B
| $48.9M | 0.52% |
1,065,770
+1,025,770
| +2,564% | +$47.1M |
|
61
Penumbra
PEN
$10.5B
| $48.7M | 0.52% |
179,875
+32,380
| +22% | +$8.76M |
|
62
Molina Healthcare
MOH
$9.6B
| $48M | 0.51% |
205,234
+5,546
| +3% | +$1.3M |
|
63
Tandem Diabetes Care
TNDM
$834M
| $46.5M | 0.49% |
527,134
+141,950
| +37% | +$12.5M |
|
64
Teladoc Health
TDOC
$1.37B
| $46.3M | 0.49% |
254,577
+44,225
| +21% | +$8.04M |
|
65
Guardant Health
GH
$8.11B
| $46.2M | 0.49% |
302,866
+123,625
| +69% | +$18.9M |
|
66
Mersana Therapeutics
MRSN
$34.8M
| $46.1M | 0.49% |
2,850,010
+924,000
| +48% | +$15M |
|
|
ABMD
67
DELISTED
Abiomed Inc
ABMD
| $45.5M | 0.48% |
142,684
+35,127
| +33% | +$11.2M |
|
68
Beam Therapeutics
BEAM
$1.9B
| $45.4M | 0.48% |
566,821
+170,000
| +43% | +$13.6M |
|
69
Zimmer Biomet
ZBH
$20.8B
| $44.8M | 0.47% |
280,082
+35,321
| +14% | +$5.65M |
|
70
Idexx Laboratories
IDXX
$50.7B
| $44.6M | 0.47% |
91,249
+13,164
| +17% | +$6.44M |
|
71
Amgen
AMGN
$153B
| $43.9M | 0.46% |
176,440
-41,550
| -19% | -$10.3M |
|
72
Omnicell
OMCL
$1.51B
| $42.6M | 0.45% |
327,919
+31,616
| +11% | +$4.11M |
|
73
AbbVie
ABBV
$374B
| $41.6M | 0.44% |
384,100
+8,600
| +2% | +$931K |
|
74
10x Genomics
TXG
$1.66B
| $41.5M | 0.44% |
229,039
+63,916
| +39% | +$11.6M |
|
75
Glaukos
GKOS
$5.42B
| $41.1M | 0.43% |
489,342
+40,010
| +9% | +$3.36M |
|